Freek W A Verheugt

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 16

Top Topics

St Segment Elevation Myocardial Infarction

Percutaneous Coronary Intervention

Cardiovascular Disease

Top Venues

Thrombosis and haemostasis

Healthcare (Basel, Switzerland)

Annals of internal medicine

Heart (British Cardiac Society)

This page only lists publications with an associated author ORCID identifier.

Publications

Freek W A Verheugt, Kurt Huber
Continuous Improvement of Antiplatelet Therapy in Cardiovascular Disease. Thrombosis and haemostasis 123 (2) (2023)
Freek W A Verheugt, Kurt Huber
Continuous Improvement of Antiplatelet Therapy in Cardiovascular Disease. Thrombosis and haemostasis 123 (2) (2023)
Lorenzo G Mantovani, Paolo Cozzolino, Pietro Ferrara, Saverio Virdone, Alan John Camm, Freek W A Verheugt, Jean-Pierre Bassand, Alexander G G Turpie, Werner Hacke, Gloria Kayani, Samuel Z Goldhaber, Shinya Goto, Karen S Pieper, Bernard J Gersh, Keith A A Fox, Sylvia Haas, Martin van Eickels, Ajay K Kakkar, null On Behalf Of The Garfield-Af Investigators
Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry. Healthcare (Basel, Switzerland) 11 (5) (2023)
Freek W A Verheugt, Kurt Huber
Continuous Improvement of Antiplatelet Therapy in Cardiovascular Disease. Thrombosis and haemostasis (2023)
Lorenzo G Mantovani, Paolo Cozzolino, Pietro Ferrara, Saverio Virdone, Alan John Camm, Freek W A Verheugt, Jean-Pierre Bassand, Alexander G G Turpie, Werner Hacke, Gloria Kayani, Samuel Z Goldhaber, Shinya Goto, Karen S Pieper, Bernard J Gersh, Keith A A Fox, Sylvia Haas, Martin van Eickels, Ajay K Kakkar, null On Behalf Of The Garfield-Af Investigators
Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry. Healthcare (Basel, Switzerland) 11 (5) (2023)
Freek W A Verheugt, Kurt Huber
Continuous Improvement of Antiplatelet Therapy in Cardiovascular Disease. Thrombosis and haemostasis 123 (2) (2023)
Freek W A Verheugt, Kurt Huber, Peter Clemmensen, Jean-Philippe Collet, Thomas Cuisset, Felicita Andreotti
Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation. Thrombosis and haemostasis 123 (2) (2022)
Karsten Schrör, Freek W A Verheugt, Dietmar Trenk
Drug-Drug Interaction between Antiplatelet Therapy and Lipid-Lowering Agents (Statins and PCSK9 Inhibitors). Thrombosis and haemostasis 123 (2) (2022)
Karsten Schrör, Freek W A Verheugt, Dietmar Trenk
Drug-Drug Interaction between Antiplatelet Therapy and Lipid-Lowering Agents (Statins and PCSK9 Inhibitors). Thrombosis and haemostasis 123 (2) (2022)
Freek W A Verheugt, Kurt Huber, Peter Clemmensen, Jean-Philippe Collet, Thomas Cuisset, Felicita Andreotti
Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation. Thrombosis and haemostasis 123 (2) (2022)
Karsten Schrör, Freek W A Verheugt, Dietmar Trenk
Drug-Drug Interaction between Antiplatelet Therapy and Lipid-Lowering Agents (Statins and PCSK9 Inhibitors). Thrombosis and haemostasis (2022)
Freek W A Verheugt, Kurt Huber, Peter Clemmensen, Jean-Philippe Collet, Thomas Cuisset, Felicita Andreotti
Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation. Thrombosis and haemostasis 123 (2) (2022)
Freek W A Verheugt, Kurt Huber, Peter Clemmensen, Jean-Philippe Collet, Thomas Cuisset, Felicita Andreotti
Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation. Thrombosis and haemostasis (2022)
Karsten Schrör, Freek W A Verheugt, Dietmar Trenk
Drug-Drug Interaction between Antiplatelet Therapy and Lipid-Lowering Agents (Statins and PCSK9 Inhibitors). Thrombosis and haemostasis 123 (2) (2022)
Alan John Camm, Keith A A Fox, Saverio Virdone, Jean-Pierre Bassand, David A Fitzmaurice, Samuel I Berchuck, Bernard J Gersh, Samuel Z Goldhaber, Shinya Goto, Sylvia Haas, Frank Misselwitz, Karen S Pieper, Alexander G G Turpie, Freek W A Verheugt, Riccardo Cappato, Ajay K Kakkar, null null
Comparative effectiveness of oral anticoagulants in everyday practice. Heart (British Cardiac Society) (2021)
Marc A Brouwer, Stijn P G van Vugt, Jeroen Jaspers Focks, Sander A J Damen, Freek W A Verheugt
Rivaroxaban Plasma Levels and Levetiracetam. Annals of internal medicine 173 (9) (2020)